2013 annual financial data
Alnylam Pharmaceuticals 2013 Operating margin
Direct answer
Operating margin was -197.05%.
Operating income was -92,942,000 USD and net income was -89,225,000 USD.
Operating cash flow was -68,657,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47,167,000 USD
- Operating income
- -92,942,000 USD
- Net income
- -89,225,000 USD
- Operating cash flow
- -68,657,000 USD